BIOMAT Database Logo BIOMAT Database Logo

Myocardial infarct size by serum troponin T and myosin light chain 1 concentration. 1995

T Omura, and M Teragaki, and M Takagi, and T Tani, and Y Nishida, and H Yamagishi, and S Yanagi, and T Nishikimi, and M Yoshiyama, and I Toda
First Department of Internal Medicine, Osaka City University Medical School, Japan.

The late troponin T (TnT) peak concentration, which is known to be independent of reperfusion of the infarcted zone in acute myocardial infarction (MI), has been suggested to be correlated with clinical estimates of cardiac function and myocardial infarct size. To refine the clinical application of the late TnT peak in infarct sizing, and to examine differences in this estimation in different infarct sites, we measured the serum concentrations of TnT and myosin light chain 1 (MLC1), and compared these values with left ventricular ejection fraction (LVEF) obtained from left ventriculography, and extent score (ES) and severity score (SS) obtained from 201Tl scintigraphy in patients with anterior and inferior myocardial infarction. The late TnT peak concentration was strongly correlated with the MLC1 peak value in patients with anterior MI (r = 0.67, p < 0.05) and in those with inferior MI (r = 0.92, p < 0.0005). Furthermore, there were strong linear correlations between the late TnT peak values and all of the clinical data (LVEF; r = -0.79, p < 0.01, ES; r = 0.75, p < 0.05, SS; r = 0.75, p < 0.05, respectively) in patients with anterior MI. However, these correlations were weak in patients with inferior MI. Similar correlations were observed between MLC1 and the clinical data. Thus, TnT and MLC1 have similar kinetics in the serum at the late phase and can be used to estimate the size of anterior infarct.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009218 Myosins A diverse superfamily of proteins that function as translocating proteins. They share the common characteristics of being able to bind ACTINS and hydrolyze MgATP. Myosins generally consist of heavy chains which are involved in locomotion, and light chains which are involved in regulation. Within the structure of myosin heavy chain are three domains: the head, the neck and the tail. The head region of the heavy chain contains the actin binding domain and MgATPase domain which provides energy for locomotion. The neck region is involved in binding the light-chains. The tail region provides the anchoring point that maintains the position of the heavy chain. The superfamily of myosins is organized into structural classes based upon the type and arrangement of the subunits they contain. Myosin ATPase,ATPase, Actin-Activated,ATPase, Actomyosin,ATPase, Myosin,Actin-Activated ATPase,Actomyosin ATPase,Actomyosin Adenosinetriphosphatase,Adenosine Triphosphatase, Myosin,Adenosinetriphosphatase, Actomyosin,Adenosinetriphosphatase, Myosin,Myosin,Myosin Adenosinetriphosphatase,ATPase, Actin Activated,Actin Activated ATPase,Myosin Adenosine Triphosphatase
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014336 Troponin One of the minor protein components of skeletal and cardiac muscles. It functions as the calcium-binding component in a complex with BETA-TROPOMYOSIN; ACTIN; and MYOSIN and confers calcium sensitivity to the cross-linked actin and myosin filaments. Troponin itself is a complex of three regulatory proteins (TROPONIN C; TROPONIN I; and TROPONIN T). Troponin Complex,Troponins
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D018994 Myosin Light Chains The smaller subunits of MYOSINS that bind near the head groups of MYOSIN HEAVY CHAINS. The myosin light chains have a molecular weight of about 20 KDa and there are usually one essential and one regulatory pair of light chains associated with each heavy chain. Many myosin light chains that bind calcium are considered "calmodulin-like" proteins. Myosin Alkali Light Chains,Myosin Alkali Light Chain,Myosin Essential Light Chain,Myosin Essential Light Chains,Myosin Light Chain,Myosin Regulatory Light Chain,Myosin Regulatory Light Chains,Light Chain, Myosin,Light Chains, Myosin

Related Publications

T Omura, and M Teragaki, and M Takagi, and T Tani, and Y Nishida, and H Yamagishi, and S Yanagi, and T Nishikimi, and M Yoshiyama, and I Toda
Myocardial infarct size from serum cardiac myosin light chain. Clinical and experimental studies.
January 1983, Advances in myocardiology,
T Omura, and M Teragaki, and M Takagi, and T Tani, and Y Nishida, and H Yamagishi, and S Yanagi, and T Nishikimi, and M Yoshiyama, and I Toda
Assessment of myocardial infarct size by serial changes in serum cardiac myosin light chain II in dogs.
June 1981, Japanese circulation journal,
T Omura, and M Teragaki, and M Takagi, and T Tani, and Y Nishida, and H Yamagishi, and S Yanagi, and T Nishikimi, and M Yoshiyama, and I Toda
Quantification of myocardial infarct size after coronary reperfusion by serum cardiac myosin light chain II in conscious dogs.
September 1989, Circulation research,
T Omura, and M Teragaki, and M Takagi, and T Tani, and Y Nishida, and H Yamagishi, and S Yanagi, and T Nishikimi, and M Yoshiyama, and I Toda
[Estimation of myocardial damage after cardiac surgery by myosin light chain I and troponin T].
November 1994, Kyobu geka. The Japanese journal of thoracic surgery,
T Omura, and M Teragaki, and M Takagi, and T Tani, and Y Nishida, and H Yamagishi, and S Yanagi, and T Nishikimi, and M Yoshiyama, and I Toda
Troponin T levels and infarct size by SPECT myocardial perfusion imaging.
May 2011, JACC. Cardiovascular imaging,
T Omura, and M Teragaki, and M Takagi, and T Tani, and Y Nishida, and H Yamagishi, and S Yanagi, and T Nishikimi, and M Yoshiyama, and I Toda
Comments on "Quantification of myocardial infarct size after coronary reperfusion by serum cardiac myosin light chain II in conscious dogs".
September 1990, Circulation research,
T Omura, and M Teragaki, and M Takagi, and T Tani, and Y Nishida, and H Yamagishi, and S Yanagi, and T Nishikimi, and M Yoshiyama, and I Toda
Serum levels of cardiac troponin I and troponin T in estimating myocardial infarct size soon after reperfusion.
July 1997, Coronary artery disease,
T Omura, and M Teragaki, and M Takagi, and T Tani, and Y Nishida, and H Yamagishi, and S Yanagi, and T Nishikimi, and M Yoshiyama, and I Toda
[Acute myocardial infarct: myosin-light-chain liberation and ventricular function].
September 1988, Klinische Wochenschrift,
T Omura, and M Teragaki, and M Takagi, and T Tani, and Y Nishida, and H Yamagishi, and S Yanagi, and T Nishikimi, and M Yoshiyama, and I Toda
Serum cardiac myosin light chain II in acute myocardial infarction; distinctive pattern of its appearance and estimation of infarct size.
March 1980, Japanese circulation journal,
T Omura, and M Teragaki, and M Takagi, and T Tani, and Y Nishida, and H Yamagishi, and S Yanagi, and T Nishikimi, and M Yoshiyama, and I Toda
[Myocardial myosin light chain].
August 1999, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!